查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1654659

全球新生儿呼吸器市场 - 2025 至 2033 年

Global Neonatal Ventilators Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 205 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球新生儿呼吸器市场规模达到 4.3906 亿美元，预计到 2033 年将达到 7.0854 亿美元，在 2025-2033 年预测期内的复合年增长率为 5.4%。

新生儿呼吸器是一种旨在为新生儿，特别是早产儿或患有呼吸系统疾病的新生儿提供呼吸支援的医疗设备。它们透过输送氧气和去除二氧化碳来控制呼吸过程，确保充分的气体交换。这些呼吸器是根据新生儿独特的生理需求而量身定制的，提供精确的压力、容量和流量控制，以最大限度地减少肺部损伤并最大限度地提供呼吸支持。它们通常用于新生儿重症监护室，治疗呼吸窘迫症候群和呼吸暂停等病症。

市场动态：

驱动因素与约束因素

早产盛行率不断上升

由于早产的增加，全球新生儿呼吸器市场正在成长，早产常常导致呼吸窘迫症候群和早产呼吸暂停等併发症。早产儿占所有活产婴儿的 10%，需要专门的呼吸器来维持生命。人们对新生儿健康的认识不断提高，以及降低死亡率的需要，凸显了新生儿呼吸器在控制日益加重的早产负担方面的重要性。

例如，根据欧洲新生儿护理基金会（EFCNI）的数据，全球每年约有 1,340 万名婴儿早产，併发症是全球 5 岁以下儿童死亡的主要原因。许多倖存者面临终身残疾，包括学习障碍和视力和听力问题。 184个国家的早产率从5％到18％不等。存活率很低，在低收入地区，出生时孕龄不超过 32 週的婴儿有一半因缺乏基本照护而死亡。在欧洲，早产是新生儿死亡的两大原因之一，占儿童后期死亡总数的一半以上。

呼吸器相关成本高昂

全球新生儿呼吸器市场因其高成本而受到阻碍，这需要大量的投资和维护，这对中低收入国家的医疗机构来说是一个挑战。这种经济负担也限制了这些设备在资源受限环境中的采用，阻碍了市场成长。例如，新生儿呼吸器的成本约为 15,000 至 20,000 美元，这是预测期内阻碍市场发展的主要因素之一。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 早产盛行率不断上升
    • 限制
      • 呼吸器相关成本高昂
    • 机会
    • 影响分析

第五章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：依产品类型

  • 侵入式呼吸机
  • 非侵入性呼吸机

第 7 章：透过移动性

  • 重症监护系统
  • 便携式系统

第 8 章：按技术

  • 机械呼吸器
  • 高频呼吸机
  • 容量定向呼吸机
  • 混合呼吸机

第 9 章：按模式

  • 压力模式通气
  • 联合模式通气
  • 容量模式通气
  • 其他模式

第 10 章：按最终用户

  • 医院
  • 新生儿门诊
  • 门诊手术中心

第 11 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Air Liquide
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Breas Medical
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • HAMILTON MEDICAL
  • Getinge Group
  • Medtronic plc
  • ICU Medical
  • Vyaire Medical
  • ResMed
  • Similar data will be provided for each market player.
  • ACUTRONIC 医疗系统股份公司
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • Vyaire 医疗公司
  • 德尔格股份公司
  • 将为每个市场参与者提供类似的资料。

第 14 章：附录

简介目录
Product Code: MD7483

The Global Neonatal Ventilators Market reached US$ 439.06 million in 2024 and is expected to reach US$ 708.54 million by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.

Neonatal ventilators are medical devices designed to provide respiratory support to newborns, especially those with preterm infants or respiratory disorders. They control the breathing process by delivering oxygen and removing carbon dioxide, ensuring adequate gas exchange. These ventilators are tailored to meet newborns' unique physiological needs, offering precise pressure, volume, and flow controls to minimize lung injury and maximize respiratory support. They are commonly used in neonatal intensive care units to manage conditions like respiratory distress syndrome and apnea.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Preterm Births

The global neonatal ventilators market is growing due to the rise in preterm births, which often result in complications like respiratory distress syndrome and apnea of prematurity. Preterm infants, who account for 10% of all live births, require specialized ventilators for life-saving support. The increasing awareness of neonatal health and the need to reduce mortality rates underscore the importance of neonatal ventilators in managing the growing burden of preterm births.

For instance, according to The European Foundation for the Care of Newborn Infants (EFCNI), Around 13.4 million babies are born preterm annually globally, with complications being the main cause of global under-5 deaths. Many survivors face lifetime disabilities, including learning disabilities and visual and hearing problems. Preterm birth rates range from 5% to 18% in 184 countries. Survival rates are stark, with low-income settings experiencing half of babies born at or below 32 weeks dying due to lack of basic care. In Europe, preterm birth is one of the two leading causes of neonatal mortality and accounts for over half of all deaths in later childhood.

High Cost associated with the Ventilators

The global market for neonatal ventilators is hindered by their high cost, which requires substantial investment and maintenance, which can be challenging for healthcare facilities in low- and middle-income countries. This financial burden also limits the adoption of these devices in resource-constrained settings, hindering market growth. For instance, the approx cost of neonatal ventilators costs around US$ 15000-US$ 20,000 which is one of the major factor that hinders the market during the forecast period.

Segment Analysis

The global Neonatal Ventilators Market is segmented based on Product Type, Mobility, Technology, Mode, End User and Region.

Product Type:

Invasive Ventilators segment is expected to dominate the Neonatal Ventilators market share

The invasive ventilators segment holds a major portion of the Neonatal Ventilators market share and is expected to continue to hold a significant portion of the Neonatal Ventilators market share during the forecast period.

Invasive ventilators are essential in the global neonatal ventilators market, particularly for newborns with severe respiratory conditions. They insert a tube into the infant's airway, typically through the trachea, to ensure a secure and controlled airway for effective ventilation. They are used in critical situations like respiratory distress syndrome, where non-invasive methods may not be sufficient. Invasive ventilators provide precise control over air pressure, volume, and oxygen delivery, essential for managing neonates' delicate lungs. The demand for these ventilators continues to grow in neonatal intensive care units worldwide.

For instance, in November 2024, Inspiration Healthcare Group has launched the SLE1500, a compact respiratory support system designed for the smallest and most vulnerable neonatal patients. This invasive ventilation mode is designed to protect their fragile lungs and is part of their specialist neonatal ventilator range.

End Users:-

Hospitals segment is the fastest-growing segment in Neonatal Ventilators market share

The hospitals segment is the fastest-growing segment in the Neonatal Ventilators market share and is expected to hold the market share over the forecast period.

The global neonatal ventilators market is largely driven by hospitals, particularly neonatal intensive care units (NICUs), which provide specialized care for newborns with critical health issues. The adoption of advanced ventilator technologies, coupled with a focus on improving neonatal outcomes and reducing mortality rates, drives market demand. The increasing number of NICUs and improvements in hospital infrastructure also contribute to market growth.

For instance, in January 2025, Gleneagles Hospitals in Parel, Mumbai has expanded its obstetrics services and introduced a new Neonatal Intensive Care Unit (NICU) to improve maternal and newborn healthcare. The NICU, equipped with four beds, is designed for neonates up to 30 days old, particularly those born prematurely or with critical conditions. It features advanced ventilators, warmers, and neurodevelopment assessment tools to manage respiratory distress, infections, and growth concerns. A team of trained pediatricians and nurses provides 24x7 monitoring and expert care.

Geographical Analysis

North America is expected to hold a significant position in the Neonatal Ventilators market share

North America holds a substantial position in the Neonatal Ventilators market and is expected to hold most of the market share due to rising preterm births, advancements in care technologies, and high healthcare expenditure. The region's well-established healthcare infrastructure and government initiatives for neonatal health, along with increased awareness and adoption of innovative ventilator technologies by leading facilities, support market expansion.

For instance, according to March of Dimes' 2024 Report Card reveals a high US preterm birth rate of 10.4%, with significant disparities among racial and ethnic groups. The report highlights the need for improved maternal and infant health outcomes and emphasizes the urgent need to prioritize the health of mothers and babies.

Europe is growing at the fastest pace in the Neonatal Ventilators market

Europe holds the fastest pace in the Neonatal Ventilators market and is expected to hold most of the market share due to government initiatives, product launches, strong healthcare policies, investment in medical device research, and key market players. The growing awareness of advanced ventilatory support and a focus on reducing neonatal mortality rates contributes to market growth in Europe.

For instance, in December 2024, Europlaz, a UK-based company, has developed a medical innovation that could improve neonatal care and save lives. The Chelmsford-based company believes that ventilator manufacturers should consider switching to this neonatal flow sensor to save lives, reduce NHS costs, and avoid costly litigation. The innovation has been developed for years.

Competitive Landscape

The major global players in the neonatal ventilators market include Air Liquide, Breas Medical, Dragerwerk AG & Co. KGaA, GE Healthcare, HAMILTON MEDICAL, Getinge Group, Medtronic plc, ICU Medical, Vyaire Medical, ResMed and among others.

Key Developments

  • In September 2024, The Fritz Stephan 'STEPHANIE' Neonatal & Infant Ventilator, designed to meet neonatal and paediatric requirements, have been officially launched at the Association of Anaesthetists Annual Congress. The new STEPHANIE, bringing 50 years of expertise, offers unique performance and a modular design structure that simplifies everyday hospital life and offers added flexibility. It is fully equipped to prepare for the ventilation of newborns and preterm infants, showcasing how clinical experience and technical expertise can create outstanding products.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Neonatal Ventilators market report delivers a detailed analysis with 78 key tables, more than 72 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Mobility & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Mobility
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Mode
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Preterm Births
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost associated with the Ventilators
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Invasive Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Invasive Ventilators

7. By Mobility

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 7.1.2. Market Attractiveness Index, By Mobility
  • 7.2. Intensive Care System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Portable System

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Mechanical ventilators*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. High frequency ventilators
  • 8.4. Volume targeted ventilators
  • 8.5. Hybrid ventilators

9. By Mode

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 9.1.2. Market Attractiveness Index, By Mode
  • 9.2. Pressure Mode Ventilation*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Combined Mode Ventilation
  • 9.4. Volume Mode Ventilation
  • 9.5. Other Modes

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neonatal Clinics
  • 10.4. Ambulatory Surgical Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Air Liquide*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Breas Medical
  • 13.3. Dragerwerk AG & Co. KGaA
  • 13.4. GE Healthcare
  • 13.5. HAMILTON MEDICAL
  • 13.6. Getinge Group
  • 13.7. Medtronic plc
  • 13.8. ICU Medical
  • 13.9. Vyaire Medical
  • 13.10. ResMed
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.11. ACUTRONIC Medical Systems AG*
    • 13.11.1. Pipeline Products Description
    • 13.11.2. Product Key Performance Indicators (KPIs)
    • 13.11.3. Key Activities
    • 13.11.4. Market Entry Timelines
    • 13.11.5. Product Penetration Rate
    • 13.11.6. Sales Estimation and Projections
  • 13.12. Vyaire Medical, Inc
  • 13.13. Dragerwerk AG & Co. KGaA
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1 About Us and Services
  • 14.2 Contact Us